Dr. Vince Clinical Research
  • Home
  • About
    • Leadership
    • Vision
    • Envisioned Around Technology
    • Green Certification
    • Careers
    • Photo Gallery
  • Services
    • Clinical Pharmacology Unit
    • Study Types
      • Human Abuse Potential
      • Early QT/TQT
    • cGMP Pharmacy
    • Support Services
  • News
  • Blog
  • Contact Us
  • Participate In A Study
Select Page

Dr. Vince Clinical Research Strengthens Investigator Team with the Addition of George Atiee, MD

by enewman | Dec 9, 2022 | Uncategorized

OVERLAND PARK, KS, December 12, 2022 (Globe Newswire) – Dr. Vince Clinical Research (DVCR) announced the addition of highly experienced investigator George J. Atiee, M.D. to the medical team at its world-class clinical pharmacology unit. Dr. Atiee has been...

Recent Posts

  • Dr. Vince Clinical Research Announces Dosing of Aclaris Therapeutics’ Phase 1 MAD Study of ATI-2138
  • Dr. Vince Clinical Research Strengthens Investigator Team with the Addition of George Atiee, MD
  • Dr. Vince Clinical Research Announces Dosing of Ensysce’s PF614 Compound in Human Abuse Potential Trial
  • Cingulate Completes Fed/Fast Study Assessing Food Effect with CTx-1301, Lead Candidate for Treatment of ADHD
  • Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit

Recent Comments

    Contact Us

    (913) 333-3000

    Headquarters

    7401 W. 91st Street
    Overland Park, KS
    66212 USA

    ABOUT

    • Leadership
    • Vision
    • Envisioned Around Technology
    • Green Certification
    • Photo Gallery

    SERVICES

    • Clinical Pharmacology Unit
    • Study Types
    • cGMP Pharmacy
    • Support Services

    Connect with us!

    • Follow
    • Follow
    Contact Us Today

    Privacy Policy | Terms & Conditions